These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18486971)

  • 1. Evaluating the benefits and costs of regulatory reforms: what questions need to be asked?
    Shapiro S
    Eval Program Plann; 2008 Aug; 31(3):223-30. PubMed ID: 18486971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive Order 12866: advantages and disadvantages of the administration's new regulatory plan on risk, benefit, and costs.
    Barnard RC
    Regul Toxicol Pharmacol; 1996 Jun; 23(3):178-82. PubMed ID: 8812959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peer review and federal regulations.
    Steinbrook R
    N Engl J Med; 2004 Jan; 350(2):103-4. PubMed ID: 14711908
    [No Abstract]   [Full Text] [Related]  

  • 4. Benefit adequacy among elderly Social Security retired-worker beneficiaries and the SSI federal benefit rate.
    Rupp K; Strand A; Davies P; Sears J
    Soc Secur Bull; 2007; 67(3):29-51. PubMed ID: 18605217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive Order 13,422, OMB's good guidance practices, and implications for health rulemaking and guidance.
    Harris MD
    J Health Life Sci Law; 2007; 1(1):127, 129-50. PubMed ID: 18610733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposing a manuscript peer-review checklist.
    Duchesne S; Jannin P
    Neuroimage; 2008 Feb; 39(4):1783-7. PubMed ID: 18053748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US agencies urged to tighten up peer review.
    Macilwain C
    Nature; 1993 Aug; 364(6437):470. PubMed ID: 8336780
    [No Abstract]   [Full Text] [Related]  

  • 8. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory policy. White House softens disputed peer-review plan.
    Kaiser J
    Science; 2004 Apr; 304(5670):496-7. PubMed ID: 15105462
    [No Abstract]   [Full Text] [Related]  

  • 10. Policy consequences of indirect regulatory costs.
    Downing PB
    Public Policy; 1981; 29(4):507-26. PubMed ID: 10309486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do we combine science and regulations for decision making following a terrorist incident involving radioactive materials?
    Poston JW; Ford JR
    Health Phys; 2009 Nov; 97(5):537-41. PubMed ID: 19820465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shifting the bell curve: the benefits and costs of raising student achievement.
    Yeh SS
    Eval Program Plann; 2009 Feb; 32(1):74-82. PubMed ID: 18977534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The politics of regulation: understanding the regulatory complex.
    Carty JP
    Pers Adm; 1980 Jun; 25(6):25-30. PubMed ID: 10246977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quality and use of regulatory analysis in 2008.
    Ellig J; McLaughlin PA
    Risk Anal; 2012 May; 32(5):855-80. PubMed ID: 22059696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engaging expert peers in the development of risk assessments.
    Meek ME; Patterson J; Strawson JE; Liteplo RG
    Risk Anal; 2007 Dec; 27(6):1609-21. PubMed ID: 18093056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presidential candidates failed peer-review test.
    Insall R
    Nature; 2004 Nov; 432(7016):439. PubMed ID: 15565125
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].
    Krauth C; John J; Aidelsburger P; Brüggenjürgen B; Hansmeier T; Hessel F; Kohlmann T; Moock J; Rothgang H; Schweikert B; Seitz R; Wasem J;
    Gesundheitswesen; 2008 Jun; 70(6):e1-16. PubMed ID: 18661452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Setting a national minimum standard for health benefits: how do state benefit mandates compare with benefits in large-group plans?
    Frey A; Mika S; Nuzum R; Schoen C
    Issue Brief (Commonw Fund); 2009 Jun; 56():1-7. PubMed ID: 19582960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating equity in regulatory and benefit-cost analysis using risk-based preferences.
    Farrow S
    Risk Anal; 2011 Jun; 31(6):902-7. PubMed ID: 20723150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A commentary on the process of peer review and pathology data locking.
    McKay JS; Barale-Thomas E; Bolon B; George C; Hardisty J; Manabe S; Schorsch F; Teranishi M; Weber K
    Toxicol Pathol; 2010 Apr; 38(3):508-10. PubMed ID: 20237370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.